Skip to main content

Table 3 Stability of the samples

From: Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS/MS with liquid liquid extraction method

Spiked plasma concentration (ng/mL)

Room temperature stability

Processed sample stability

Long term stability

Freeze and thaw stability

 

24.5 h

71.5 h

55 days

Cycle 3 (48 h)

Concentration measured

CV.a(n = 6) (%)

Concentration measured

CVa(n = 6) (%)

Concentration measured

CV.a(n = 6) (%)

Concentration measured

CV.a(n = 6) (%)

(n = 6)

(n = 6)

(n = 6)

(n = 6)

(ng/mL)

(ng/mL)

(ng/mL)

(ng/mL)

(mean ± S.D)

(mean ± S.D)

(mean ± S.D)

(mean ± S.D)

3.00

3.09 ± 0.16

5.26

3.11 ± 0.12

4.00

3.03 ± 0.08

2.56

3.04 ± 0.16

5.11

4800.00

5034.29 ± 62.49

1.24

4800.00 ± 104.74

2.18

4800.80 ± 172.50

3.59

4923.81 ± 148.20

3.01

  1. a (Standard deviation/mean concentration measured)X100.